Monoclonal antibody shows promising results for rare liver disease

A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver ...
ahajournals.org

2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association

The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage.” The 2023 guideline ...
gut.bmj

Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy

3 School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China 4 Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA Objective A close ...
Zacks Investment Research on MSN

Will strong Livmarli uptake continue to aid MIRM's revenues in 2026?

Mirum Pharmaceuticals’ MIRM revenue base is largely supported by its lead product, Livmarli (maralixibat), which has been ...
Healio

VIDEO: Treatment outlook ‘rapidly changing’ in primary sclerosing cholangitis

Please provide your email address to receive an email when new articles are posted on . “Traditionally, we haven’t paid a lot of attention to symptoms in PSC, except when patients have acute ...